Guangzhou University of Chinese Medicine
9
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Fu's Subcutaneous Needling for Postacute Lateral Ankle Sprain and Prevention of Chronic Ankle Instability
Role: lead
Clinical Study on the Healing of Distal Radius Fractures With Conservative Treatment Assisted by Fu's Subcutaneous Needling
Role: lead
Efficacy and Mechanism of Fu's Subcutaneous Needling Treatment for Migraine Without Aura
Role: lead
Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma: A Real-world Study in China
Role: lead
Prospective Validation of CARPET Prognostic Model for Septic Shock After Allo-HSCT
Role: collaborator
A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness
Role: collaborator
Effects of an Integrative Learning Program on Community Dwelling Old People With Dementia
Role: collaborator
Thunder-Fire Moxibustion Therapy for Chronic Fatigue Syndrome on Shenque Acupoint: a Randomized Controlled Trial
Role: lead
Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
Role: lead
All 9 trials loaded